News Release

CINJ and RWJUH Host Most Successful Prostate Cancer Screening in 13 Years

More than 700 Men Tested over a Three-day Period
November 2, 2011


New Brunswick, N.J. – Reaching a significant landmark in their annual prostate cancer screening event, The Cancer Institute of New Jersey (CINJ) and Robert Wood Johnson University Hospital (RWJUH) have announced that more than 700 men were tested recently over a three-day period. This figure surpasses the number of attendees who participated in previous years and brings the total number of men checked over the past five years to around 3,000. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

For the thirteenth consecutive year, the Dean and Betty Gallo Prostate Cancer Center at CINJ joined with the RWJUH Community Health Promotion Program to organize the event. Extremely pleased with the outstanding turnout, Mariam Merced, director of RWJUH’s Community Health Promotion Program, said the success of this year's screening is a product of community strength. "Churches and civic groups from the region continue to encourage their members to be screened. This in turn translates into additional family and friends taking part," she said. "With the amount of participants increasing each year, we are confident that many more lives will be saved from prostate cancer."

According to the American Cancer Society, an estimated 241,000 men will be diagnosed with prostate cancer this year in the U.S., with an estimated 34,000 deaths. CINJ urologic oncologist Thomas L. Jang, MD, MPH, who led the clinical component of this year’s screening, noted that the best available studies show that screening men for prostate cancer saves lives. "The goal is to find aggressive cancers that are potentially curable at an early stage, so these men can have a successful outcome while limiting over-detection and over-treatment of less harmful cancers," said Dr. Jang, who is also an assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School.

About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ's physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. Follow us on Facebook at www.facebook.com/TheCINJ.

The CINJ Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Medical Center, Carol G. Simon Cancer Center at Overlook Medical Center, and Cooper University Hospital. Affiliate Hospitals: CentraState Healthcare System, JFK Medical Center, Mountainside Hospital, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), Somerset Medical Center, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate

About Robert Wood Johnson University Hospital
Robert Wood Johnson University Hospital (RWJUH) is a 600-bed academic medical center and the principal hospital of UMDNJ-Robert Wood Johnson Medical School in New Brunswick, NJ. Robert Wood Johnson is an innovative leader in advancing state-of-the-art care. RWJUH is the first hospital in the nation to implant the AbioCor self-contained artificial heart since the device received FDA approval in 2006. RWJUH is one of only three sites in the nation approved to offer this groundbreaking technology. Its Centers of Excellence include cardiovascular care from minimally invasive heart surgery to transplantation, cancer care, and women’s and children’s care including The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital (www.bmsch.org). The hospital is also a Level 1 Trauma Center and serves as a national resource in its ground-breaking approaches to emergency preparedness. The hospital has earned significant national recognition for clinical quality and patient safety. RWJUH ranks among the best hospitals in America, according to U.S. News & World Report’s 2010 ranking of “America’s Best Hospitals.” It is the fourth consecutive year that RWJUH has achieved this prestigious ranking. The American College of Surgeons’ Commission on Cancer has rated RWJUH among the nation's best comprehensive cancer centers. The Leapfrog Group rated RWJUH as one of the 50 exceptional U.S. hospitals, as published in Consumers Digest magazine. Harvard University researchers, in a study commissioned by The Commonwealth Fund, identified RWJUH as one of the top 10 hospitals in the nation for clinical quality. RWJUH is also a four-time recipient of the prestigious Magnet Award for Nursing Excellence. Visit us online at www.rwjuh.edu.

Contact: 
Michele Fisher
Phone: 
732-235-9872